As with any other respiratory test or procedure, particularly during the current Covid-19 pandemic, it is important to be aware of infection risk and take measures to prevent transmission.
FeNO testing has been assessed as a low risk procedure by the Association for Respiratory Technology and Physiology (ARTP). You can review their approach to assessment following the link below. Table 1 from the document is show here for your reference.
The FeNO product suppliers (Circassia and Bedfont) have also put together valuable resources and information around the risks of Coronavirus transmission and the safe, effective care for NObreath and NIOX VERO device in the context of infection control. You can access these resources using the links below;
1. Bedfont general information and guidance around Coronavirus
3. Guidance and care of NIOX VERO product